HSCT in Paroxysmal Nocturnal Hemoglobinuria

Get up to date on menin inhibitors, an emerging class of targeted therapies for acute myeloid leukemia (AML). Menin is a key component of the KMT2A (lysine methyltransferase 2A, formerly MLL1) complex, which plays a critical role in gene regulation, development, and cell cycle co ...  Show more

Get up to date with the EHA–ESMO guidelines on Human immunodeficiency virus (HIV)-associated Lymphomas. In this episode, Prof. Kai Hubel, a key author of the guidelines, explains the importance of having dedicated recommendations for patients with HIV-associated lymphomas. He beg ...  Show more

Alyssa and Callum talk through Aspergillus, the first of our Moulds series. After you hear the puns in this episode you'll be fumi(n)g at us. Tune in to hear about:EpidemiologyTaxonomyPathogenesisLab identificationOn the next episode we'll be joined by some special guest to delve ...  Show more

Send us Fan MailPremium Member Resources: https://ninjanerd.orgWelcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we discuss Glomerular Diseases, including Nephrotic and Nephritic Syndrome. You'll learn about the causes, symptoms, and treatment options for Glom ...  Show more

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...

This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease.